1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Middle East & Africa Poultry Vaccines Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Middle East & Africa Poultry Vaccines Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Prevalence of Poultry Diseases
5.2 Market Opportunities
- 5.2.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.3 Future Trends
- 5.3.1 Advancements in vectored and combination vaccines
5.4 Impact of Drivers and Restraints
6. Middle East & Africa Poultry Vaccines Market Regional Analysis
6.1 Middle East & Africa Poultry Vaccines Market Overview
6.2 Middle East & Africa Poultry Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Middle East & Africa Poultry Vaccines Market Forecast Analysis
7. Middle East & Africa Poultry Vaccines Market Analysis – by Type
7.1 Broiler
- 7.1.1 Overview
- 7.1.2 Broiler: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Layer
- 7.2.1 Overview
- 7.2.2 Layer: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Breeder
- 7.3.1 Overview
- 7.3.2 Breeder: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Poultry Vaccines Market Analysis – by Technology
8.1 Live Attenuated Vaccines
- 8.1.1 Overview
- 8.1.2 Live Attenuated Vaccines: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Inactivated Vaccines
- 8.2.1 Overview
- 8.2.2 Inactivated Vaccines: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Recombinant Vaccines
- 8.3.1 Overview
- 8.3.2 Recombinant Vaccines: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Poultry Vaccines Market Analysis – by Dosage Form
9.1 Liquid vaccines
- 9.1.1 Overview
- 9.1.2 Recombinant Vaccines: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Freeze-Dried Vaccines
- 9.2.1 Overview
- 9.2.2 Recombinant Vaccines: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dust/Powdered Vaccines
- 9.3.1 Overview
- 9.3.2 Recombinant Vaccines: Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Poultry Vaccines Market – Middle East and Africa Analysis
10.1 Middle East and Africa
- 10.1.1 Middle East & Africa Poultry Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Middle East & Africa Poultry Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 South Africa:
Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 South Africa: Middle East & Africa Poultry Vaccines Market Breakdown, by Type
- 10.1.1.1.2 South Africa: Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.1.3 South Africa: Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage Form
- 10.1.1.2 Saudi Arabia:
Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Saudi Arabia: Middle East & Africa Poultry Vaccines Market Breakdown, by Type
- 10.1.1.2.2 Saudi Arabia: Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.2.3 Saudi Arabia: Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage Form
- 10.1.1.3 UAE:
Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 UAE: Middle East & Africa Poultry Vaccines Market Breakdown, by Type
- 10.1.1.3.2 UAE: Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.3.3 UAE: Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage Form
- 10.1.1.4 Rest of Middle East and Africa:
Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Poultry Vaccines Market Breakdown, by Type
- 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage Form
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Middle East & Africa Poultry Vaccines Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Boehringer Ingelheim Intrnational GmbH.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Zoitis Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Ceya Santae Animale.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BIOVAC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 PHIBRO ANIMAL HEALTH CORPORATION.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hester Biosciences Limited.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Dechra Pharmaceutical Plc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Elanco.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Merck Animal Health.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights